386 related articles for article (PubMed ID: 12490598)
1. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
2. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
3. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
[TBL] [Abstract][Full Text] [Related]
4. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
Schiffelers SL; Blaak EE; Saris WH; van Baak MA
Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
[TBL] [Abstract][Full Text] [Related]
5. An effect of extrarenal beta adrenergic stimulation on the release of renin.
Reid IA; Schrier RW; Earley LE
J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
[TBL] [Abstract][Full Text] [Related]
6. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
7. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
8. Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat.
Lewis SJ; Hoque A; Walton TM; Kooy NW
Eur J Pharmacol; 2005 Aug; 518(2-3):187-94. PubMed ID: 16043170
[TBL] [Abstract][Full Text] [Related]
9. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
10. Role of beta-3-adrenoceptor in catecholamine-induced relaxations in gastric fundus from control and diabetic rats.
Ozakca I; Arioglu E; Guner S; Altan VM; Ozcelikay AT
Pharmacology; 2007; 80(4):227-38. PubMed ID: 17622774
[TBL] [Abstract][Full Text] [Related]
11. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
Yorikane R; Kanda A; Kimura T; Satoh S
J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
[TBL] [Abstract][Full Text] [Related]
12. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
Angelone T; Filice E; Quintieri AM; Imbrogno S; Recchia A; Pulerà E; Mannarino C; Pellegrino D; Cerra MC
Acta Physiol (Oxf); 2008 Jul; 193(3):229-39. PubMed ID: 18208582
[TBL] [Abstract][Full Text] [Related]
13. Functional beta3-adrenoceptor in the human heart.
Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H
J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
Yamazaki J; Sugimoto T; Yabana H; Nagao T
J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
[TBL] [Abstract][Full Text] [Related]
16. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
17. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
19. Influence of beta-adrenoceptor agonists on the pulmonary circulation. Effects of a beta3-adrenoceptor antagonist, SR 59230A.
Dumas M; Dumas JP; Bardou M; Rochette L; Advenier C; Giudicelli JF
Eur J Pharmacol; 1998 May; 348(2-3):223-8. PubMed ID: 9652337
[TBL] [Abstract][Full Text] [Related]
20. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
Clin Exp Pharmacol Physiol; 2005; 32(1-2):30-4. PubMed ID: 15730431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
